Cargando…
Following successful anti-leishmanial treatment, neutrophil counts, CD10 expression and phagocytic capacity remain reduced in visceral leishmaniasis patients co-infected with HIV
Visceral leishmaniasis (VL) patients co-infected with HIV (VL/HIV patients) experience frequent treatment failures, VL relapses, opportunistic infections, and higher mortality. Their immune system remains profoundly suppressed after clinical cure and they maintain higher parasite load. This is in co...
Autores principales: | Takele, Yegnasew, Adem, Emebet, Mulaw, Tadele, Müller, Ingrid, Cotton, James Anthony, Kropf, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410551/ https://www.ncbi.nlm.nih.gov/pubmed/35969625 http://dx.doi.org/10.1371/journal.pntd.0010681 |
Ejemplares similares
-
Recurrent visceral leishmaniasis relapses in HIV co-infected patients are characterized by less efficient immune responses and higher parasite load
por: Takele, Yegnasew, et al.
Publicado: (2022) -
Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV
por: Takele, Yegnasew, et al.
Publicado: (2021) -
Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia
por: Franssen, Susanne U., et al.
Publicado: (2021) -
Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation
por: Takele, Yegnasew, et al.
Publicado: (2022) -
Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-γ, but not IL-10 Production
por: Adem, Emebet, et al.
Publicado: (2016)